Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2003
12/30/2003US6670386 For therapy of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia
12/30/2003US6670375 Particularly, 8-aza-, 8-carbo- and 8-oxo- tropanes having 6-or 7-substituents; preferred are the dopamine transporter, the serotonin transporter and the norepinephrine transporter.
12/30/2003US6670373 Compounds and method for inhibiting MRP1
12/30/2003US6670372 Aryl ether substituted imidazoquinolines
12/30/2003US6670371 Antagonists of Corticotropin-Releasing Factor
12/30/2003US6670365 Substituted imidazo 1,2a}azines as selective inhibitors of cox-2
12/30/2003US6670364 Antagonists of MCP-1 function and methods of use thereof
12/30/2003CA2293621C 4-aminopyrrole(3,2-d) pyrimidines as neuropeptide y receptor antagonists
12/30/2003CA2266015C Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
12/30/2003CA2052884C Angiotensin 11 antagonists in the treatment of hyperuricemia
12/30/2003CA2040086C Novel 2,9-disubstituted-4h-pyrido[1,2-a]pyrimidin-4-ones
12/25/2003US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS
12/25/2003US20030236296 Novel interleukin-1beta converting enzyme inhibitors
12/25/2003US20030236282 Cardiovascular disorders; antiinflammatory agents; skin disorders
12/25/2003US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
12/25/2003US20030236279 Central nervous system disorders; psychological disorders
12/25/2003US20030236278 Serotonine receptors antagonist; central nervous system disorders
12/25/2003US20030236277 Viricides; immunomoderators
12/25/2003US20030236276 Phosphodiesterase inhibitor; anticancer agents
12/25/2003US20030236271 Antitumor agents; enzyme inhibitors
12/25/2003US20030236263 Chemical compounds
12/25/2003US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents
12/25/2003US20030236259 Novel aryl- and heteroarylpiperazines
12/25/2003US20030236251 Hepatitis virus viricides
12/25/2003US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins
12/25/2003US20030236244 Antiallergens; autoimmune diseases; antiproliferative agents; controlling signal transduction
12/25/2003US20030236241 Psychological disorders; drug abuse
12/25/2003US20030236229 For stimulating the immune system, treating proliferative disorders, or microbial infections
12/25/2003US20030234379 Dicationic viologens, such as methyl viologen and benzyl viologen, associated with anions selected from bis(trifluoro-methyl(or perfluoroethyl)sulfonyl)imide and tris(trifluoro-methylsulfonyl)methide; soluble in quat ammonium melts
12/24/2003WO2003106460A1 Novel interleukin-1 beta converting enzyme inhibitors
12/24/2003WO2003106457A1 Spiroindolinepiperidine derivatives
12/24/2003WO2003106450A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
12/24/2003WO2003106446A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
12/24/2003WO2003106435A1 Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof
12/24/2003WO2003106429A1 Prodrug and process for producing the same
12/24/2003WO2003106413A2 Process for the preparation of oxazolidinones and method of use thereof
12/24/2003WO2003106402A1 2-naphtamide derivatives
12/24/2003WO2003105845A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
12/24/2003WO2003062236A8 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES
12/24/2003WO2003020280B1 Compositions and use thereof in the treatment of cancer
12/24/2003WO2002090356A3 Method for the production of zolpidem
12/24/2003WO2002085901A8 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists)
12/24/2003CN1463269A Phenylpiperazine
12/24/2003CN1462749A Preparing anti-cancer active material in camptothecinum cell and method for restraining eancer cell
12/24/2003CN1131865C 作为选择性COX－2抑制剂的取代的咪唑并[1,2a]吖嗪 Substituted imidazole as selective COX-2 inhibitors and [1,2a] azines
12/24/2003CN1131854C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
12/24/2003CN1131670C Antifungal active compound compsns.
12/24/2003CA2489470A1 Prodrug and process for producing the same
12/24/2003CA2489361A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
12/24/2003CA2489286A1 2-naphtamide derivatives
12/24/2003CA2489252A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
12/24/2003CA2464109A1 Process for the preparation of oxazolidinones and method of use thereof
12/23/2003US6667339 Contraceptive
12/23/2003US6667322 Useful for treatment of diseases such as obsessive compulsive disorder, panic attacks, anxiety, sexual dysfunction, eating disorders, obesity, addictive disorders
12/23/2003US6667316 Pharmaceutically active isoindoline derivatives
12/23/2003US6667313 8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators
12/23/2003US6667312 Thioether substituted imidazoquinolines
12/23/2003US6667305 Alzheimer's disease; beta-amyloid peptide is a small fragment of the amyloid precursor protein
12/23/2003US6667304 Affinity for melatonin receptors; sleep disorders; N-(2-(2-methoxy-6H-pyrido(2',3':4,5)pyrrolo(2,1-a)isoindol-11 -yl)ethyl)acetamide; N-(2-(3-methoxy-6,7,8,9-tetrahydropyrido (3,2-b)indolizin-5-yl) ethyl)acetamide
12/23/2003CA2307080C Process for preparing 8-cyclopentyl-6-ethyl-3-¬substituted|-5,8-dihydro-4h-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
12/23/2003CA2267800C Tricyclic compounds having activity as ras-fpt inhibitors
12/23/2003CA2233178C (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/20/2003CA2424443A1 Chlorin and bacteriochlorin-based difunctional aminophenyl dtpa and n2s2 conjugates for mr contrast media and radiopharmaceuticals
12/18/2003WO2003104379A1 Ligand and complex for catalytically bleaching a substrate
12/18/2003WO2003104236A1 Calcitonin gene related peptide receptor antagonists
12/18/2003WO2003104235A1 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]pyrazines and decahydropyrazino[1,2-a]azepines
12/18/2003WO2003104234A1 Ligand and complex for catalytically bleaching a substrate
12/18/2003WO2003104233A1 4,5-dihydro-imidazo (4,5,1-ij) quinolin-6-ones derivatives and their use as poly (adp-ribosyl) transferase (parp) inhibitors
12/18/2003WO2003104232A1 1,6,9,14-tetrasubstituted terrylene tetracarboxylic acid diimides
12/18/2003WO2003104231A1 NOVEL INTERLEUKIN-1beta CONVERTING ENZYME INHIBITORS
12/18/2003WO2003104230A1 Bicyclic pyrimidine derivatives
12/18/2003WO2003104229A1 Novel fused imidazole derivative
12/18/2003WO2003104228A1 Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction
12/18/2003WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003WO2003103669A1 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
12/18/2003WO2003103666A2 Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones
12/18/2003WO2003103610A2 Mappicine analogs, methods of inhibiting retroviral reverse transcriptase and methods of treating retroviruses
12/18/2003WO2003103590A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003WO2003103584A2 Ether substituted imidazopyridines
12/18/2003WO2003103575A2 Compounds, compositions, and methods
12/18/2003WO2003087087A3 Heterocyclic compounds and their use as modulators of p38 map kinase
12/18/2003WO2003066630A3 Quinolinone derivatives for treating cell proliferation related disorders
12/18/2003WO2003044021A3 Substituted indolizine-like compounds and methods of use
12/18/2003WO2003024401A3 Piperizinones as modulators of chemokine receptor activity
12/18/2003WO2003015773A3 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases
12/18/2003WO2002038561A8 Indolylmaleimide derivatives as protein kinase c inhibitors
12/18/2003US20030232853 Azabicyclic compounds for the treatment of disease
12/18/2003US20030232852 Nitrogen compounds such as 2-(ethoxymethyl)-1-(2-methylpropyl) -6-methyl-1H-imidazo(4,5-c)pyridin-4-amine hydrochloride, formed by amination of chemical intermediates for use as viricides or immunology modulators
12/18/2003US20030232851 Viral treatment
12/18/2003US20030232850 Heterocyclic amines such as 2-benzoyl-1,3,4,9-tetrahydro-2H-pyrido(3,4-b)indole, used preferential inhibitors of fatty acid biosynthesis in bacterial systems; bactericides
12/18/2003US20030232847 Imidazo-substituted compounds as p38 kinase inhibitors
12/18/2003US20030232846 Caspase inhibitors and uses thereof
12/18/2003US20030232839 Administering heterocyclic amines, as controllers of central nervous system(CNS) such as serotonin receptors
12/18/2003US20030232821 Oxadiazine derivatives
12/18/2003US20030232818 Antibacterial compounds
12/18/2003US20030232816 Benzimidazole derivatives
12/18/2003US20030232804 Glycinamides as factor Xa inhibitors
12/18/2003US20030232732 Ligand and complex for catalytically bleaching a substrate
12/18/2003US20030232215 Organic Red Electro-Luminescent Device and Dopant
12/18/2003CA2488801A1 Ether substituted imidazopyridines
1 ... 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 ... 646